Steven M. Lipkin

10.8k total citations · 4 hit papers
107 papers, 6.2k citations indexed

About

Steven M. Lipkin is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Steven M. Lipkin has authored 107 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 41 papers in Oncology and 39 papers in Pathology and Forensic Medicine. Recurrent topics in Steven M. Lipkin's work include Genetic factors in colorectal cancer (38 papers), Cancer Genomics and Diagnostics (25 papers) and BRCA gene mutations in cancer (14 papers). Steven M. Lipkin is often cited by papers focused on Genetic factors in colorectal cancer (38 papers), Cancer Genomics and Diagnostics (25 papers) and BRCA gene mutations in cancer (14 papers). Steven M. Lipkin collaborates with scholars based in United States, Israel and Germany. Steven M. Lipkin's co-authors include Christopher K. Glass, Xiling Shen, Michael G. Rosenfeld, Anders M. Näär, Diana Dizon, Robert A. Edwards, Mavee Witherspoon, Jeffrey M. Holloway, Victor C. Yu and Argyrios Ziogas and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Steven M. Lipkin

103 papers receiving 6.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The orientation and spacing of core DNA-binding motifs dictate selective transcriptional responses to three nuclear receptors

1991 533 citations Steven M. Lipkin et al. profile →
A pan-cancer mycobiome analysis reveals fungal involvement in gastrointestinal and lung tumors

2022 247 citations Steven M. Lipkin, Xiling Shen et al. profile →
NOTCH Signaling Is Required for Formation and Self-Renewal of Tumor-Initiating Cells and for Repression of Secretory Cell Differentiation in Colon Cancer

2010 225 citations Shaheen S. Sikandar, Kira T. Pate et al. Cancer Research profile →
Poly(carboxybetaine) lipids enhance mRNA therapeutics efficacy and reduce their immunogenicity

2025 18 citations Steven M. Lipkin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven M. Lipkin United States	39	3.9k	1.7k	1.5k	1.4k	1.0k	107	6.2k
Valerie Speirs United Kingdom	46	3.7k 0.9×	3.1k 1.8×	2.2k 1.5×	2.5k 1.8×	618 0.6×	194	8.0k
Rakesh Kumar United States	47	4.6k 1.2×	2.2k 1.3×	1.2k 0.8×	1.7k 1.2×	445 0.4×	160	7.1k
Santo V. Nicosia United States	43	4.6k 1.2×	2.2k 1.3×	1.9k 1.3×	1.0k 0.7×	1.4k 1.3×	117	8.6k
Paula M. Vertino United States	49	7.7k 2.0×	1.4k 0.8×	1.3k 0.9×	1.4k 1.0×	515 0.5×	105	9.5k
Barbara C. Vanderhyden Canada	49	3.6k 0.9×	1.3k 0.8×	851 0.6×	1.4k 1.0×	346 0.3×	151	7.5k
Pearlly S. Yan United States	50	6.5k 1.7×	1.7k 1.0×	1.7k 1.2×	1.3k 0.9×	435 0.4×	139	8.6k
Steffi Oesterreich United States	49	4.7k 1.2×	2.5k 1.5×	1.8k 1.2×	1.8k 1.3×	415 0.4×	216	7.8k
Priscilla A. Furth United States	44	3.8k 1.0×	2.4k 1.4×	955 0.6×	2.2k 1.6×	269 0.3×	144	6.8k
Stephen P. Naber United States	37	2.4k 0.6×	1.9k 1.1×	836 0.6×	700 0.5×	304 0.3×	87	4.6k
Jiro Fujimoto Japan	39	3.6k 0.9×	1.5k 0.9×	898 0.6×	1.2k 0.8×	576 0.6×	234	7.4k

Countries citing papers authored by Steven M. Lipkin

Since Specialization

Citations

This map shows the geographic impact of Steven M. Lipkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Lipkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Lipkin more than expected).

Fields of papers citing papers by Steven M. Lipkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Lipkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Lipkin. The network helps show where Steven M. Lipkin may publish in the future.

Co-authorship network of co-authors of Steven M. Lipkin

This figure shows the co-authorship network connecting the top 25 collaborators of Steven M. Lipkin. A scholar is included among the top collaborators of Steven M. Lipkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven M. Lipkin. Steven M. Lipkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lv, Chao, Mohd Puad Abdullah, Chun‐Li Su, et al.. (2025). Genomic characterization of Escherichia coli with a polyketide synthase (pks) island isolated from ulcerative colitis patients. BMC Genomics. 26(1). 19–19. 2 indexed citations

Viladomiu, Monica, Belgin Dogan, Svetlana Lima, et al.. (2022). Agr2-associated ER stress promotes adherent-invasive E. coli dysbiosis and triggers CD103+ dendritic cell IL-23-dependent ileocolitis. Cell Reports. 41(7). 111637–111637. 10 indexed citations

Chen, Siwei, Yuan Liu, Yingying Zhang, et al.. (2021). A full-proteome, interaction-specific characterization of mutational hotspots across human cancers. Genome Research. 32(1). 135–149. 3 indexed citations

Ravichandran, Vignesh, Yelena Kemel, Michael F. Walsh, et al.. (2019). Toward automation of germline variant curation in clinical cancer genetics. Genetics in Medicine. 21(9). 2116–2125. 21 indexed citations

Artomov, Mykyta, Joseph Vijai, Grace Tiao, et al.. (2019). Case–control analysis identifies shared properties of rare germline variation in cancer predisposing genes. European Journal of Human Genetics. 27(5). 824–828. 4 indexed citations

Choi, Jiahn, Nikolai Rakhilin, Daniel J. Joe, et al.. (2018). Intestinal crypts recover rapidly from focal damage with coordinated motion of stem cells that is impaired by aging. Scientific Reports. 8(1). 10989–10989. 23 indexed citations

Lencz, Todd, Jin Yu, Cameron D. Palmer, et al.. (2018). High-depth whole genome sequencing of an Ashkenazi Jewish reference panel: enhancing sensitivity, accuracy, and imputation. Human Genetics. 137(4). 343–355. 15 indexed citations

Crespo, Miguel, Eduardo Vilar, Su‐Yi Tsai, et al.. (2017). Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing. Nature Medicine. 23(7). 878–884. 293 indexed citations

Srinivasan, Tara, Jewell Walters, Pengcheng Bu, et al.. (2016). NOTCH Signaling Regulates Asymmetric Cell Fate of Fast- and Slow-Cycling Colon Cancer–Initiating Cells. Cancer Research. 76(11). 3411–3421. 44 indexed citations

10.

Gillen, Daniel L., Frank L. Meyskens, Timothy R. Morgan, et al.. (2015). A Phase IIa Randomized, Double-Blind Trial of Erlotinib in Inhibiting Epidermal Growth Factor Receptor Signaling in Aberrant Crypt Foci of the Colorectum. Cancer Prevention Research. 8(3). 222–230. 2 indexed citations

11.

Wei, Xiaomu, Jishnu Das, Robert Fragoza, et al.. (2014). A Massively Parallel Pipeline to Clone DNA Variants and Examine Molecular Phenotypes of Human Disease Mutations. PLoS Genetics. 10(12). e1004819–e1004819. 37 indexed citations

12.

Witherspoon, Mavee, Qiuying Chen, Levy Kopelovich, Steven S. Gross, & Steven M. Lipkin. (2013). Unbiased Metabolite Profiling Indicates That a Diminished Thymidine Pool Is the Underlying Mechanism of Colon Cancer Chemoprevention by Alpha-Difluoromethylornithine. Cancer Discovery. 3(9). 1072–1081. 37 indexed citations

13.

Sun, Jian, Robert A. Edwards, Diana Dizon, et al.. (2012). miR-23a Promotes the Transition from Indolent to Invasive Colorectal Cancer. Cancer Discovery. 2(6). 540–553. 127 indexed citations

14.

Lipkin, Steven M., J. Jack Lee, David K. Imagawa, et al.. (2011). Phase IIA Trial Testing Erlotinib as an Intervention against Intraductal Pancreatic Mucinous Neoplasms. Cancer Prevention Research. 4(4). 512–513. 4 indexed citations

15.

Lipkin, Steven M., Elizabeth Chao, Vı́ctor Moreno, et al.. (2010). Genetic Variation in 3-Hydroxy-3-Methylglutaryl CoA Reductase Modifies the Chemopreventive Activity of Statins for Colorectal Cancer. Cancer Prevention Research. 3(5). 597–603. 57 indexed citations

16.

Sikandar, Shaheen S., Kira T. Pate, Scott Anderson, et al.. (2010). NOTCH Signaling Is Required for Formation and Self-Renewal of Tumor-Initiating Cells and for Repression of Secretory Cell Differentiation in Colon Cancer. Cancer Research. 70(4). 1469–1478. 225 indexed citations breakdown →

17.

Edwards, Robert A., Mavee Witherspoon, Kehui Wang, et al.. (2009). Epigenetic Repression of DNA Mismatch Repair by Inflammation and Hypoxia in Inflammatory Bowel Disease–Associated Colorectal Cancer. Cancer Research. 69(16). 6423–6429. 61 indexed citations

18.

Lipkin, Steven M.. (2007). Hereditary colorectal cancer. Cancer Epidemiology and Prevention Biomarkers. 16. 1 indexed citations

19.

Lipkin, Steven M., et al.. (2006). Molecular cancer prevention: Phase IIa trial of Erlotinib for IPMNs and the prevention of pancreatic cancer.. Cancer Epidemiology and Prevention Biomarkers. 15. 1 indexed citations

20.

Chen, Peng‐Chieh, Sandra Dudley, Diana Dizon, et al.. (2005). Contributions by MutL Homologues Mlh3 and Pms2 to DNA Mismatch Repair and Tumor Suppression in the Mouse. Cancer Research. 65(19). 8662–8670. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact